![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: PON2 |
Gene summary for PON2 |
![]() |
Gene information | Species | Human | Gene symbol | PON2 | Gene ID | 5445 |
Gene name | paraoxonase 2 | |
Gene Alias | PON2 | |
Cytomap | 7q21.3 | |
Gene Type | protein-coding | GO ID | GO:0006725 | UniProtAcc | A0A0J9YYG4 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
5445 | PON2 | LZE2T | Human | Esophagus | ESCC | 2.50e-02 | 6.18e-01 | 0.082 |
5445 | PON2 | LZE4T | Human | Esophagus | ESCC | 4.43e-08 | 2.67e-01 | 0.0811 |
5445 | PON2 | LZE5T | Human | Esophagus | ESCC | 6.72e-04 | 6.60e-01 | 0.0514 |
5445 | PON2 | LZE7T | Human | Esophagus | ESCC | 4.42e-08 | 6.60e-01 | 0.0667 |
5445 | PON2 | LZE8T | Human | Esophagus | ESCC | 3.57e-07 | 3.84e-01 | 0.067 |
5445 | PON2 | LZE22T | Human | Esophagus | ESCC | 1.90e-07 | 8.70e-01 | 0.068 |
5445 | PON2 | LZE6T | Human | Esophagus | ESCC | 1.03e-02 | 5.38e-01 | 0.0845 |
5445 | PON2 | P1T-E | Human | Esophagus | ESCC | 2.29e-09 | 6.73e-01 | 0.0875 |
5445 | PON2 | P2T-E | Human | Esophagus | ESCC | 9.02e-56 | 1.05e+00 | 0.1177 |
5445 | PON2 | P4T-E | Human | Esophagus | ESCC | 4.25e-32 | 8.69e-01 | 0.1323 |
5445 | PON2 | P5T-E | Human | Esophagus | ESCC | 9.22e-30 | 7.32e-01 | 0.1327 |
5445 | PON2 | P8T-E | Human | Esophagus | ESCC | 6.51e-45 | 8.84e-01 | 0.0889 |
5445 | PON2 | P9T-E | Human | Esophagus | ESCC | 1.61e-18 | 5.69e-01 | 0.1131 |
5445 | PON2 | P10T-E | Human | Esophagus | ESCC | 1.88e-50 | 9.56e-01 | 0.116 |
5445 | PON2 | P11T-E | Human | Esophagus | ESCC | 1.59e-29 | 1.19e+00 | 0.1426 |
5445 | PON2 | P12T-E | Human | Esophagus | ESCC | 1.24e-56 | 9.41e-01 | 0.1122 |
5445 | PON2 | P15T-E | Human | Esophagus | ESCC | 4.19e-44 | 1.22e+00 | 0.1149 |
5445 | PON2 | P16T-E | Human | Esophagus | ESCC | 4.92e-57 | 1.14e+00 | 0.1153 |
5445 | PON2 | P17T-E | Human | Esophagus | ESCC | 4.82e-13 | 8.85e-01 | 0.1278 |
5445 | PON2 | P19T-E | Human | Esophagus | ESCC | 5.40e-13 | 1.11e+00 | 0.1662 |
Page: 1 2 3 4 5 6 7 8 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:007121910 | Oral cavity | OSCC | cellular response to molecule of bacterial origin | 112/7305 | 221/18723 | 2.64e-04 | 1.69e-03 | 112 |
GO:000181910 | Oral cavity | OSCC | positive regulation of cytokine production | 213/7305 | 467/18723 | 1.93e-03 | 8.96e-03 | 213 |
GO:00027022 | Oral cavity | OSCC | positive regulation of production of molecular mediator of immune response | 58/7305 | 117/18723 | 1.28e-02 | 4.27e-02 | 58 |
GO:00024441 | Oral cavity | OSCC | myeloid leukocyte mediated immunity | 50/7305 | 99/18723 | 1.31e-02 | 4.34e-02 | 50 |
GO:0006979110 | Oral cavity | LP | response to oxidative stress | 181/4623 | 446/18723 | 5.74e-14 | 6.10e-12 | 181 |
GO:001943916 | Oral cavity | LP | aromatic compound catabolic process | 176/4623 | 467/18723 | 1.96e-10 | 1.08e-08 | 176 |
GO:000961516 | Oral cavity | LP | response to virus | 143/4623 | 367/18723 | 7.42e-10 | 3.52e-08 | 143 |
GO:005160711 | Oral cavity | LP | defense response to virus | 97/4623 | 265/18723 | 9.31e-06 | 1.74e-04 | 97 |
GO:014054611 | Oral cavity | LP | defense response to symbiont | 97/4623 | 265/18723 | 9.31e-06 | 1.74e-04 | 97 |
GO:003249618 | Oral cavity | LP | response to lipopolysaccharide | 112/4623 | 343/18723 | 4.90e-04 | 4.60e-03 | 112 |
GO:007121616 | Oral cavity | LP | cellular response to biotic stimulus | 84/4623 | 246/18723 | 5.17e-04 | 4.82e-03 | 84 |
GO:000223718 | Oral cavity | LP | response to molecule of bacterial origin | 115/4623 | 363/18723 | 1.42e-03 | 1.13e-02 | 115 |
GO:000963619 | Oral cavity | LP | response to toxic substance | 86/4623 | 262/18723 | 1.74e-03 | 1.32e-02 | 86 |
GO:007122214 | Oral cavity | LP | cellular response to lipopolysaccharide | 69/4623 | 209/18723 | 3.99e-03 | 2.59e-02 | 69 |
GO:000961514 | Prostate | Tumor | response to virus | 101/3246 | 367/18723 | 6.40e-07 | 1.32e-05 | 101 |
GO:000181914 | Prostate | Tumor | positive regulation of cytokine production | 109/3246 | 467/18723 | 4.98e-04 | 3.67e-03 | 109 |
GO:003249616 | Prostate | Tumor | response to lipopolysaccharide | 81/3246 | 343/18723 | 1.74e-03 | 1.03e-02 | 81 |
GO:000223716 | Prostate | Tumor | response to molecule of bacterial origin | 83/3246 | 363/18723 | 3.95e-03 | 2.00e-02 | 83 |
GO:00027202 | Prostate | Tumor | positive regulation of cytokine production involved in immune response | 20/3246 | 65/18723 | 5.60e-03 | 2.63e-02 | 20 |
GO:00516073 | Prostate | Tumor | defense response to virus | 62/3246 | 265/18723 | 6.92e-03 | 3.13e-02 | 62 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PON2 | SNV | Missense_Mutation | c.396C>A | p.Asn132Lys | p.N132K | Q15165 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AO-A03O-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Chemotherapy | doxorubicin | SD | |
PON2 | insertion | Nonsense_Mutation | novel | c.102_103insTATTGTATTCTCACATCCTATTGACCCAAACTTAGACATAT | p.Glu35TyrfsTer8 | p.E35Yfs*8 | Q15165 | protein_coding | TCGA-A7-A0CG-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
PON2 | SNV | Missense_Mutation | c.333N>G | p.Phe111Leu | p.F111L | Q15165 | protein_coding | deleterious(0.04) | benign(0.118) | TCGA-C5-A1BQ-01 | Cervix | cervical & endocervical cancer | Female | >=65 | III/IV | Chemotherapy | cisplatin | CR | |
PON2 | SNV | Missense_Mutation | c.139G>A | p.Gly47Arg | p.G47R | Q15165 | protein_coding | deleterious(0.01) | possibly_damaging(0.879) | TCGA-FU-A3HZ-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
PON2 | SNV | Missense_Mutation | c.619N>C | p.Tyr207His | p.Y207H | Q15165 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AA-3672-01 | Colorectum | colon adenocarcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD | |
PON2 | SNV | Missense_Mutation | c.261G>T | p.Met87Ile | p.M87I | Q15165 | protein_coding | tolerated(0.08) | benign(0.003) | TCGA-CA-6717-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Chemotherapy | oxaliplatin | CR | |
PON2 | SNV | Missense_Mutation | novel | c.743N>G | p.Glu248Gly | p.E248G | Q15165 | protein_coding | deleterious(0) | possibly_damaging(0.572) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
PON2 | SNV | Missense_Mutation | c.860N>A | p.Gly287Asp | p.G287D | Q15165 | protein_coding | deleterious(0.03) | possibly_damaging(0.865) | TCGA-CK-5913-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
PON2 | SNV | Missense_Mutation | c.442G>A | p.Ala148Thr | p.A148T | Q15165 | protein_coding | deleterious(0.03) | benign(0.039) | TCGA-AG-A014-01 | Colorectum | rectum adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
PON2 | deletion | Frame_Shift_Del | c.195delT | p.Phe65LeufsTer5 | p.F65Lfs*5 | Q15165 | protein_coding | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
5445 | PON2 | DRUGGABLE GENOME, ENZYME | antidepressants |
Page: 1 |